ask="9.23"
ask_size="2000"
average_daily_volume="164724"
bid="4.20"
bid_size="200"
book_value="0.00"
change="+0.01"
change_from_200_day_moving_average="6.09"
change_from_50_day_moving_average="4.35"
change_from_52_week_high="-5.57"
change_From_52_week_low="2.13"
change_in_percent="+0.12%"
close="8.23"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="8.38"
high_52_weeks="13.80"
last_trade_date="1/4/2017"
last_trade_price="8.23"
last_trade_size="200"
last_trade_time="4:00pm"
low="8.20"
low_52_weeks="6.10"
market_capitalization="762.54B"
moving_average_200_day="2.14"
moving_average_50_day="3.88"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="13.50"
open="8.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+284.16%"
percent_change_from_50_day_moving_average="+112.30%"
percent_change_from_52_week_high="-40.36%"
percent_change_from_52_week_low="+34.92%"
previous_close="8.22"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="92654000000"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="76387"
weeks_range_52="6.10 - 13.80"
